Cargando…
Adenosine-Mono-Phosphate-Activated Protein Kinase-Independent Effects of Metformin in T Cells
The anti-diabetic drug metformin regulates T-cell responses to immune activation and is proposed to function by regulating the energy-stress-sensing adenosine-monophosphate-activated protein kinase (AMPK). However, the molecular details of how metformin controls T cell immune responses have not been...
Autores principales: | Zarrouk, Marouan, Finlay, David K., Foretz, Marc, Viollet, Benoit, Cantrell, Doreen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152329/ https://www.ncbi.nlm.nih.gov/pubmed/25181053 http://dx.doi.org/10.1371/journal.pone.0106710 |
Ejemplares similares
-
AMPKα1: A glucose sensor that controls CD8 T-cell memory
por: Rolf, Julia, et al.
Publicado: (2013) -
LKB1 Mediates the Development of Conventional and Innate T Cells via AMP-Dependent Kinase Autonomous Pathways
por: Zarrouk, Marouan, et al.
Publicado: (2013) -
Metformin: update on mechanisms of action and repurposing potential
por: Foretz, Marc, et al.
Publicado: (2023) -
Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation
por: Vara-Ciruelos, Diana, et al.
Publicado: (2019) -
Metformin lowers glucose 6-phosphate in hepatocytes by activation of glycolysis downstream of glucose phosphorylation
por: Moonira, Tabassum, et al.
Publicado: (2020)